Text Size
6 studies found for:    17538086 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Sirolimus, Idarubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Conditions: Adult Acute Megakaryoblastic Leukemia (M7);   Adult Acute Monoblastic Leukemia (M5a);   Adult Acute Monocytic Leukemia (M5b);   Adult Acute Myeloblastic Leukemia With Maturation (M2);   Adult Acute Myeloblastic Leukemia Without Maturation (M1);   Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities;   Adult Acute Myeloid Leukemia With Del(5q);   Adult Acute Myeloid Leukemia With Inv(16)(p13;q22);   Adult Acute Myeloid Leukemia With t(16;16)(p13;q22);   Adult Acute Myeloid Leukemia With t(8;21)(q22;q22);   Adult Acute Myelomonocytic Leukemia (M4);   Adult Erythroleukemia (M6a);   Adult Pure Erythroid Leukemia (M6b);   Untreated Adult Acute Myeloid Leukemia
Interventions: Drug: Sirolimus;   Drug: Idarubicin;   Drug: Cytarabine
2 Recruiting Multicenter Dose-escalation Study of a Combination of Pazopanib and Bevacizumab in Patients With Metastatic Renal Cell Carcinoma or Others Advanced Solid Tumors
Conditions: Metastatic Renal Cell Carcinoma;   Advanced Refractory Solid Tumors Histologically or Cytologically Confirmed
Intervention: Drug: Association of Bevacizumab (BVC)+ Pazopanib (PZP)
3 Recruiting Erlotinib and Temsirolimus for Solid Tumors
Condition: Solid Tumors
Intervention: Drug: erlotinib and temsirolimus
4 Completed Combination of Temsirolimus and Bevacizumab in Patient With Metastatic Renal Cell Carcinoma
Condition: Metastatic Renal Cell Carcinoma
Interventions: Drug: Temsirolimus;   Drug: Bevacizumab;   Drug: Sunitinib;   Drug: Interferon alpha-2a
5 Completed Temsirolimus and Radiation for Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Temsirolimus;   Radiation: Radiation therapy
6 Completed
Has Results 		Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma
Conditions: Carcinoma, Renal Cell;   Kidney Neoplasms
Interventions: Drug: Interferon Alfa;   Drug: CCI-779;   Drug: Interferon Alfa and CCI-779
To Top

† Indicates status has not been verified in more than two years